LICENSE AGREEMENTLicense Agreement • March 18th, 2020 • Erytech Pharma S.A. • Biological products, (no disgnostic substances) • Delaware
This LICENSE AGREEMENT (this “Agreement”) is entered into as of June 24, 2019 (the “Effective Date”) by and between ERYTECH Pharma, Société Anonyme, incorporated in France at the companies and trades registry under number 479 560 013 rcs Lyon, with a share capital of €1,794,003.50 and having its registered office at Bâtiment Adénine, 60 Avenue Rockefeller, 69008 Lyon, FRANCE represented by Mr. Gil BEYEN, Chief Executive Officer (“Erytech”), and SQZ Biotechnologies Company, a Delaware corporation with offices located at 134 Coolidge Avenue, Watertown, MA 02472 (“SQZ”). Erytech and SQZ are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 18th, 2020 • Erytech Pharma S.A. • Biological products, (no disgnostic substances) • Massachusetts
THIS EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is effective as of April 1, 2019 (the “Effective Date”) by and between ERYTECH Pharma, Inc., (the “Company”), and Gil Beyen (“Executive”) (collectively referred to as the “Parties” or individually referred to as a “Party”).
